PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 17 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,332 | -35.9% | 22,398 | -3.4% | 0.00% | – |
| Q3 2022 | $13,000 | -35.0% | 23,198 | -16.5% | 0.00% | – |
| Q2 2022 | $20,000 | -84.5% | 27,793 | -78.4% | 0.00% | – |
| Q4 2021 | $129,000 | +50.0% | 128,724 | +205.5% | 0.00% | – |
| Q3 2021 | $86,000 | -9.5% | 42,137 | +0.6% | 0.00% | – |
| Q2 2021 | $95,000 | – | 41,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 360,094 | $637,000 | 2.24% |
| SABBY MANAGEMENT, LLC | 255,194 | $452,000 | 0.19% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 12,500 | $22,000 | 0.00% |
| UBS Group AG | 563 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 18 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 12,375 | $22,000 | 0.00% |
| MORGAN STANLEY | 86 | $0 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |